MDLive
Provider comparison
Patients who already use MDLIVE for primary care; it isn't built for comparing GLP-1 prices.
- Semaglutide / month
- Not disclosed
- Tirzepatide / month
- Not disclosed
Index 50/100 · Grade CChecked October 2026
MDLive vs VigorMeds
Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.
By The WeighLab Bench. Provider verification dates appear below.
VigorMeds
Provider comparison
Shoppers who want a needle-free sublingual GLP-1 that costs meaningfully less than the injectable, from named physicians.
- Semaglutide / month
- $199/moStarting dose, compounded
- Tirzepatide / month
- $299/moStarting dose, compounded
Index 50/100 · Grade CChecked August 2026
Compounded drugs are not FDA-approved. Understand the medication options.
Check VigorMeds pricing Read reviewWe may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.
The comparison in brief
Both score 50/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.
Check the difference in state access
- MDLive
- GLP-1 access restricted by state and health plan; confirm eligibility
- VigorMeds
- Coverage not published
The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.
How the comparison is scoredCosts & coverage
Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.
MDLive
VigorMeds
- Semaglutide / month
- MDLive: Not disclosed
- VigorMeds: $199/moStarting dose, compounded
- Tirzepatide / month
- MDLive: Not disclosed
- VigorMeds: $299/moStarting dose, compounded
- Semaglutide / year (modeled)
- MDLive: —
- VigorMeds: $2,388
- Tirzepatide / year (modeled)
- MDLive: —
- VigorMeds: $3,588
- State availability
- MDLive: GLP-1 access restricted by state and health plan; confirm eligibility
- VigorMeds: Coverage not published
- Oral / sublingual option listed
- MDLive: Not listed
- VigorMeds: Yes
- Brand-name access listed
- MDLive: Yes
- VigorMeds: Not confirmed
- Provider facts checked
- MDLive: October 2026
- VigorMeds: August 2026
Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.
Which program fits your priorities?
The strengths and limitations behind each provider's score. Read the full review before deciding.
MDLive
Patients who already use MDLIVE for primary care; it isn't built for comparing GLP-1 prices.
Reasons to consider it
- Established virtual primary-care service through participating health plans
- Can prescribe FDA-approved Wegovy and Zepbound when clinically appropriate
- Medication can be sent to your preferred pharmacy
What to weigh up
- GLP-1s require a Primary Care Routine Care visit; urgent care and wellness screenings do not qualify
- Medication-specific cash prices are not published
- GLP-1 prescribing is unavailable in certain states; confirm current eligibility
VigorMeds
Shoppers who want a needle-free sublingual GLP-1 that costs meaningfully less than the injectable, from named physicians.
Reasons to consider it
- Both injectable and needle-free sublingual forms of semaglutide ($139/mo) and tirzepatide ($159/mo) — the sublingual tier is $60-$140/mo cheaper than the injectable tier
- Named, credentialed clinicians reviewing cases: Dr. Anthony Kane MD, Dr. Claudia Mondragon MD, Dr. Kevin Kargman MD, Stephanie Kowatch MSN FNP-C
- 'Pay upon medical approval' — no charge until a provider signs off on treatment, plus a 30-day satisfaction guarantee
What to weigh up
- Its 'States We Serve' page names no actual states, only vague buckets like 'Coming soon' and 'Room to grow', so confirm yours before you start
- The FIRST100 promo code discounts whichever tier is chosen by $100 for the first month, so the price shown at signup is not the ongoing rate
- No compounding pharmacy is named; prescribing is routed through OLA Health LLC and unnamed independent providers
Compounded drugs are not FDA-approved. Understand the medication options.
Check VigorMeds pricing Read the full VigorMeds reviewExplore the six scoring factors
Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.
MDLiveVigorMeds
- Normalized Cost/Month
- MDLive: 45/100
- VigorMeds: 59/100
- Price Transparency
- MDLive: 54/100
- VigorMeds: 30/100
- Nationwide Access
- MDLive: 24/100
- VigorMeds: 24/100
- Formulation Options
- MDLive: 53/100
- VigorMeds: 77/100
- Clinical Oversight
- MDLive: 85/100
- VigorMeds: 78/100
- Contract Flexibility
- MDLive: 55/100
- VigorMeds: 41/100
Before you sign up
- Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
- Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
- Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.
Keep comparing
More provider matchups
Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.